19:50 EDT Nektar (NKTR) trading halted, news pending
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NKTR:
- Nektar Therapeutics Approves Reverse Stock Split
- Nektar Therapeutics Elects New Board, Approves Key Proposals
- Anticipated Clinical Trial Results and Financial Stability Justify Buy Rating for Nektar Therapeutics
- Nektar Therapeutics’ Earnings Call Highlights Progress and Challenges
- Nektar Therapeutics Reports Q1 2025 Financial Results